MX9201711A - METHOD TO DELAY AND REDUCE THE APPEARANCE OF VIRUS RESISTANT TO NUCLEOSID ANALOGS, IN A PATIENT WHO HAS AN HIV INFECTION. - Google Patents

METHOD TO DELAY AND REDUCE THE APPEARANCE OF VIRUS RESISTANT TO NUCLEOSID ANALOGS, IN A PATIENT WHO HAS AN HIV INFECTION.

Info

Publication number
MX9201711A
MX9201711A MX9201711A MX9201711A MX9201711A MX 9201711 A MX9201711 A MX 9201711A MX 9201711 A MX9201711 A MX 9201711A MX 9201711 A MX9201711 A MX 9201711A MX 9201711 A MX9201711 A MX 9201711A
Authority
MX
Mexico
Prior art keywords
delay
patient
appearance
reduce
hiv infection
Prior art date
Application number
MX9201711A
Other languages
Spanish (es)
Inventor
William A Carter
Original Assignee
Hem Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Pharma Corp filed Critical Hem Pharma Corp
Publication of MX9201711A publication Critical patent/MX9201711A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MX9201711A 1991-04-16 1992-04-13 METHOD TO DELAY AND REDUCE THE APPEARANCE OF VIRUS RESISTANT TO NUCLEOSID ANALOGS, IN A PATIENT WHO HAS AN HIV INFECTION. MX9201711A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68620091A 1991-04-16 1991-04-16

Publications (1)

Publication Number Publication Date
MX9201711A true MX9201711A (en) 1992-10-01

Family

ID=24755338

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9201711A MX9201711A (en) 1991-04-16 1992-04-13 METHOD TO DELAY AND REDUCE THE APPEARANCE OF VIRUS RESISTANT TO NUCLEOSID ANALOGS, IN A PATIENT WHO HAS AN HIV INFECTION.

Country Status (10)

Country Link
EP (1) EP0581906A4 (en)
JP (1) JPH06507624A (en)
CN (1) CN1082819C (en)
AU (1) AU671800B2 (en)
CA (1) CA2102221A1 (en)
IE (1) IE920873A1 (en)
MX (1) MX9201711A (en)
PT (1) PT100340A (en)
WO (1) WO1992018004A1 (en)
ZA (1) ZA922755B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820696A (en) * 1985-08-26 1989-04-11 Hem Research, Inc. Modulation of aids virus-related events by double-stranded RNAS
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
US4945082A (en) * 1985-08-26 1990-07-31 Hem Research, Inc. Controlled dsRNA therapy for human viral infections
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases

Also Published As

Publication number Publication date
CN1082819C (en) 2002-04-17
EP0581906A4 (en) 1997-07-23
CA2102221A1 (en) 1992-10-17
AU671800B2 (en) 1996-09-12
EP0581906A1 (en) 1994-02-09
WO1992018004A1 (en) 1992-10-29
AU1871892A (en) 1992-11-17
IE920873A1 (en) 1992-10-21
ZA922755B (en) 1993-04-28
JPH06507624A (en) 1994-09-01
PT100340A (en) 1993-07-30
CN1068035A (en) 1993-01-20

Similar Documents

Publication Publication Date Title
ES2187530T3 (en) PEPTIDES TO REDUCE T CTITOTOXY LYMPHOCYTE RESPONSES TO HEPATITIS B VIRUSES.
DE68920915T2 (en) Extraction and purification of an anticoagulant from the South American leeches Haementeria ghilianii.
SE9602931D0 (en) New medicinal use
ES2123048T3 (en) ANTIVIRIC NUCLEOSID ANALOGS.
EP0230574A3 (en) Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
FR2669346B1 (en) RECOMBINANT POXVIRUS VACCINE AGAINST MEALS.
ES2053953T3 (en) USE OF HEPARIN FRACTIONS OR HEPARIN FRAGMENTS.
FR2683723B1 (en) NEW ANTIVIRAL DRUGS ACTIVE ON THE HIV VIRUS.
DE68910577D1 (en) AIDS virus remedy.
ES2181502T3 (en) TREATMENT OF HEPATITIS B INFECTION WITH ALFA 1 TIMOSINE AND LAMIVUDINE.
WO1990013281A3 (en) Method of suppressing hiv infection
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
FI890116A0 (en) ICKE-REVERTERANDE RNA VIRUS.
MX9201711A (en) METHOD TO DELAY AND REDUCE THE APPEARANCE OF VIRUS RESISTANT TO NUCLEOSID ANALOGS, IN A PATIENT WHO HAS AN HIV INFECTION.
ITVR940096A0 (en) PROCEDURE AND EQUIPMENT FOR THE SPECIFIC IMMUNADORPTION OF HIV VIRUS, GP120 ANTIGEN AND CD4-GP120 COMPLEX.
ES1016092Y (en) DISPOSABLE AND STERILE LINGUAL ANATOMIC DEPRESSOR, FOR THE EXPLORATION OF THE ISTHUM OF THE FAUCES AND THE PHARYNX.
DK720588D0 (en) RELATIONSHIPS TO USE IN TREATMENT OR PREVENTION OF HUMAN IMMUNE INFECTIVE VIRUS (HIV) INFECTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
KR900007816A (en) Cyclopropyl-substituted azolylmethylcarbinol, its preparation method and its use as a medicament
ES2162862T3 (en) USE OF TIMOSINE TO TREAT HEPATITIS C IN PATIENTS WHO DO NOT RESPOND TO THE INTERFER TREATMENT.
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
DE3886155T2 (en) Anthracycline derivatives with inhibitory activity against the reverse transcriptase of the human immunodeficiency virus.
ES2160927T3 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE INTERFERED NATURAL HUMAN ALPHA.
UA41338C2 (en) Method for inhibiting retroviral infection caused by human immunodeficiency virus (hiv), method for inhibiting human immunodeficiency virus (hiv)
ZA945416B (en) Method of inhibiting the production of infectious human immunodeficiency viruses (HIV) in HIV seropositive humans.
WO1993014760A3 (en) Methods